Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Rapamycin modulation of p70 S6 kinase signaling inhibits Rift Valley fever virus pathogenesis.

Bell TM, Espina V, Senina S, Woodson C, Brahms A, Carey B, Lin SC, Lundberg L, Pinkham C, Baer A, Mueller C, Chlipala EA, Sharman F, de la Fuente C, Liotta L, Kehn-Hall K.

Antiviral Res. 2017 Jul;143:162-175. doi: 10.1016/j.antiviral.2017.04.011. Epub 2017 Apr 23.

2.

Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection.

Benedict A, Bansal N, Senina S, Hooper I, Lundberg L, de la Fuente C, Narayanan A, Gutting B, Kehn-Hall K.

Front Microbiol. 2015 Jul 8;6:676. doi: 10.3389/fmicb.2015.00676. eCollection 2015.

3.

Small molecule inhibitors of Ago2 decrease Venezuelan equine encephalitis virus replication.

Madsen C, Hooper I, Lundberg L, Shafagati N, Johnson A, Senina S, de la Fuente C, Hoover LI, Fredricksen BL, Dinman J, Jacobs JL, Kehn-Hall K.

Antiviral Res. 2014 Dec;112:26-37. doi: 10.1016/j.antiviral.2014.10.002. Epub 2014 Oct 18.

PMID:
25448087
4.

The role of IKKβ in Venezuelan equine encephalitis virus infection.

Amaya M, Voss K, Sampey G, Senina S, de la Fuente C, Mueller C, Calvert V, Kehn-Hall K, Carpenter C, Kashanchi F, Bailey C, Mogelsvang S, Petricoin E, Narayanan A.

PLoS One. 2014 Feb 19;9(2):e86745. doi: 10.1371/journal.pone.0086745. eCollection 2014.

5.

Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.

Guendel I, Iordanskiy S, Van Duyne R, Kehn-Hall K, Saifuddin M, Das R, Jaworski E, Sampey GC, Senina S, Shultz L, Narayanan A, Chen H, Lepene B, Zeng C, Kashanchi F.

J Virol. 2014 Jan;88(2):1189-208. doi: 10.1128/JVI.01940-13. Epub 2013 Nov 13.

6.

Curcumin inhibits Rift Valley fever virus replication in human cells.

Narayanan A, Kehn-Hall K, Senina S, Lundberg L, Van Duyne R, Guendel I, Das R, Baer A, Bethel L, Turell M, Hartman AL, Das B, Bailey C, Kashanchi F.

J Biol Chem. 2012 Sep 28;287(40):33198-214. Epub 2012 Jul 30.

7.

Modulation of GSK-3β activity in Venezuelan equine encephalitis virus infection.

Kehn-Hall K, Narayanan A, Lundberg L, Sampey G, Pinkham C, Guendel I, Van Duyne R, Senina S, Schultz KL, Stavale E, Aman MJ, Bailey C, Kashanchi F.

PLoS One. 2012;7(4):e34761. doi: 10.1371/journal.pone.0034761. Epub 2012 Apr 4.

8.

Liver X receptor agonist inhibits HIV-1 replication and prevents HIV-induced reduction of plasma HDL in humanized mouse model of HIV infection.

Dubrovsky L, Van Duyne R, Senina S, Guendel I, Pushkarsky T, Sviridov D, Kashanchi F, Bukrinsky M.

Biochem Biophys Res Commun. 2012 Mar 2;419(1):95-8. doi: 10.1016/j.bbrc.2012.01.137. Epub 2012 Feb 4.

9.

Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.

Boyer JL, Sofer-Podesta C, Ang J, Hackett NR, Chiuchiolo MJ, Senina S, Perlin D, Crystal RG.

Hum Gene Ther. 2010 Jul;21(7):891-901. doi: 10.1089/hum.2009.148.

10.

Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge.

Sofer-Podesta C, Ang J, Hackett NR, Senina S, Perlin D, Crystal RG, Boyer JL.

Infect Immun. 2009 Apr;77(4):1561-8. doi: 10.1128/IAI.00856-08. Epub 2009 Jan 5.

11.

Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection.

Chattopadhyay A, Park S, Delmas G, Suresh R, Senina S, Perlin DS, Rose JK.

Vaccine. 2008 Nov 25;26(50):6329-37. doi: 10.1016/j.vaccine.2008.09.031. Epub 2008 Oct 1.

12.

Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen.

Chiuchiolo MJ, Boyer JL, Krause A, Senina S, Hackett NR, Crystal RG.

J Infect Dis. 2006 Nov 1;194(9):1249-57. Epub 2006 Sep 25.

PMID:
17041851
13.

An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge.

Palin A, Chattopadhyay A, Park S, Delmas G, Suresh R, Senina S, Perlin DS, Rose JK.

Vaccine. 2007 Jan 8;25(4):741-50. Epub 2006 Aug 22.

PMID:
16959385

Supplemental Content

Loading ...
Support Center